Global Polio Eradication through the Introduction of the Inactivated Polio Vaccine

Reporting Organization:WHO - World Health Organization
Total Budget ($CAD):$ 20,000,000
Timeframe: March 31, 2015 - March 31, 2017
Status: Completion
Contact Information: Unspecified

Partner & Funder Profiles

Reporting Organization

WHO - World Health Organization

Participating Organizations

Funders (Total Budget Contribution)

Return to top


Region - Total Budget Allocation

Sub-Saharan Africa - $ 8,814,000.00 (44.07%)

Southeast Asia - $ 3,332,000.00 (16.66%)

South Asia - $ 2,726,000.00 (13.63%)

East Asia - $ 2,424,000.00 (12.12%)

Central Asia - $ 1,516,000.00 (7.58%)

North Africa - $ 1,186,000.00 (5.93%)

Return to top

Areas of Focus

Health - Total Budget Allocation

Infectious & Communicable Diseases (100 %)

Return to top


WHO supports countries who do not receive support from Gavi to boost populations’ long term immunity to polio through the withdrawal of Oral Polio Vaccines (OPV) and the introduction of injectable Inactivated Polio Vaccines (IPV). These are critical components of the Polio Eradication and Endgame Strategic Plan (2013-2018). Non-Gavi countries who are eligible to introduce IPV will apply to WHO for a one-time grant to cost-share vaccine introduction, as a means of strengthening national routine immunization programs. WHO will coordinate with UNICEF to procure the required IPV vaccines and provide countries with technical support to deliver, store and track vaccines, thereby helping to increase immunization coverage and reduce preventable child mortality. This project directly supports the Global Polio Eradication Initiative’s (GPEI) Polio Eradication and Endgame Strategic Plan goal of achieving polio eradication by 2018. This project contributes to Canada’s $250 million commitment made to the GPEI at the 2013 Abu Dhabi Vaccine Summit for support to the GPEI Endgame Strategy (2013- 2018), and complements the efforts of Gavi to introduce IPV.

Return to top

Target Population

Gender and age: Unspecified
Total Direct Population: Unspecified
Return to top



Return to top

Results & Indicators

Expected Results

Expected outcomes for this project are: strengthened immunity against wild polio virus (WPV) and circulating vaccine-derived poliovirus (cVDPV), and increased inactive polio vaccine (IPV) coverage.

Achieved Results



  • None Selected
Return to top
Return to top

Associated Projects (If applicable)

Return to top